|
Sign In to gain access to subscriptions and/or personal tools.
|
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines
I. M. Anderson
University of Manchester Department of Psychiatry, University of Manchester, Oxford Road, Manchester, ian.anderson{at}man.ac.uk
D. J. Nutt
University of Bristol, Psychopharmacology Unit, School of Medical Sciences, Bristol, UK
J. F. W. Deakin
University of Manchester Department of Psychiatry, University of Manchester, Oxford Road, Manchester
A revision of the British Association for Psychopharmacology guidelines for treating depressive disorders with antidepressants was undertaken in order to specify the scope and target of the guidelines and to update the recommendations based explicitly on the available evidence. A consensus meeting, involving experts in depressive disorders and their treatment, reviewed key areas and considered the strength of evidence and clinical implications. The guidelines were drawn up after extensive feedback from participants and interested parties. A literature review is given which identifies the quality of evidence followed by recommendations, the strength of which are based on the level of evidence. The guidelines cover the nature and detection of depressive disorders, acute treatment with antidepressant drugs, choice of drug versus alternative treatment, practical issues in prescribing, management when initial treatment fails, continuation treatment, maintenance treatment to prevent recurrence and stopping treatment.
Journal of Psychopharmacology, Vol. 14, No. 1,
3-20 (2000)
DOI: 10.1177/026988110001400101
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
I. Omori, N Watanabe, A Nakagawa, T Akechi, A Cipriani, C Barbui, H McGuire, R Churchill, and T. Furukawa
Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis
J Psychopharmacol,
July 1, 2009;
23(5):
539 - 550.
[Abstract]
[PDF]
|
|
|
|
|
|
|
T. Kendrick, C. Dowrick, A. McBride, A. Howe, P. Clarke, S. Maisey, M. Moore, and P. W Smith
Management of depression in UK general practice in relation to scores on depression severity questionnaires: analysis of medical record data
BMJ,
March 19, 2009;
338(mar19_1):
b750 - b750.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Maj
Depression, Bereavement, and "Understandable" Intense Sadness: Should the DSM-IV Approach Be Revised?
Am J Psychiatry,
November 1, 2008;
165(11):
1373 - 1375.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A Vanoli, C. Lane, C. Harrison, N. Steen, and A. Young
Adequacy of venlafaxine dose prescribing in major depression and hospital resources implications
J Psychopharmacol,
June 1, 2008;
22(4):
434 - 440.
[Abstract]
[PDF]
|
|
|
|
|
|
|
I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al.
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
J Psychopharmacol,
June 1, 2008;
22(4):
343 - 396.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Tint, P. M Haddad, and I. M Anderson
The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study
J Psychopharmacol,
May 1, 2008;
22(3):
330 - 332.
[Abstract]
[PDF]
|
|
|
|
|
|
|
O. Morgan, C. Griffiths, and A. Majeed
Antidepressant prescribing and changes in antidepressant poisoning mortality and suicide in England, 1993-2004
J Public Health,
March 1, 2008;
30(1):
60 - 68.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Fujita, H. Azuma, T. Kitamura, K. Takahashi, T. Akechi, and T. A. Furukawa
Adequacy of continuation and maintenance treatments for major depression in Japan
J Psychopharmacol,
March 1, 2008;
22(2):
153 - 156.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. J. Rush, M. H. Trivedi, S. R. Wisniewski, A. A. Nierenberg, J. W. Stewart, D. Warden, G. Niederehe, M. E. Thase, P. W. Lavori, B. D. Lebowitz, et al.
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
Focus,
January 1, 2008;
6(1):
128 - 142.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Haddad and I. M. Anderson
Recognising and managing antidepressant discontinuation symptoms
Adv. Psychiatr. Treat.,
November 1, 2007;
13(6):
447 - 457.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. M. ANDERSON, N. A. DELVAI, B. ASHIM, S. ASHIM, C. LEWIN, V. SINGH, D. STURMAN, and P. L. STRICKLAND
Adjunctive fast repetitive transcranial magnetic stimulation in depression
The British Journal of Psychiatry,
June 1, 2007;
190(6):
533 - 534.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Pollock
Maintaining face in the presentation of depression: constraining the therapeutic potential of the consultation
Health (London) ,
April 1, 2007;
11(2):
163 - 180.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. J. Nutt, K. Fone, P. Asherson, D. Bramble, P. Hill, K. Matthews, K. A. Morris, P. Santosh, E. Sonuga-Barke, E. Taylor, et al.
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology
J Psychopharmacol,
January 1, 2007;
21(1):
10 - 41.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Burns and J. O'Brien
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology
J Psychopharmacol,
November 1, 2006;
20(6):
732 - 755.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. J. Rush, M. H. Trivedi, S. R. Wisniewski, A. A. Nierenberg, J. W. Stewart, D. Warden, G. Niederehe, M. E. Thase, P. W. Lavori, B. D. Lebowitz, et al.
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
Am J Psychiatry,
November 1, 2006;
163(11):
1905 - 1917.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. G. RUHE, J. HUYSER, J. A. SWINKELS, and A. H. SCHENE
Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorder: Systematic review
The British Journal of Psychiatry,
October 1, 2006;
189(4):
309 - 316.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. MITCHELL
Two-week delay in onset of action of antidepressants: new evidence
The British Journal of Psychiatry,
February 1, 2006;
188(2):
105 - 106.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S. McIntyre, J. Z. Konarski, D. A. Mancini, K. A. Fulton, S. V. Parikh, S. Grigoriadis, L. A. Grupp, D. Bakish, M.-J. Filteau, C. Gorman, et al.
Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale
Can. Med. Assoc. J.,
November 22, 2005;
173(11):
1327 - 1334.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Baldwin, I. M. Anderson, D. J. Nutt, B. Bandelow, A. Bond, J. R. T. Davidson, J. A. den Boer, N. A. Fineberg, M. Knapp, J. Scott, et al.
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
J Psychopharmacol,
November 1, 2005;
19(6):
567 - 596.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. L. Kravitz, R. M. Epstein, M. D. Feldman, C. E. Franz, R. Azari, M. S. Wilkes, L. Hinton, and P. Franks
Influence of Patients' Requests for Direct-to-Consumer Advertised Antidepressants: A Randomized Controlled Trial
JAMA,
April 27, 2005;
293(16):
1995 - 2002.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Maxwell
Women's and doctors' accounts of their experiences of depression in primary care: the influence of social and moral reasoning on patients' and doctors' decisions
Chronic Illness,
March 1, 2005;
1(1):
61 - 71.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. I. F. Scott
College guidelines on electroconvulsive therapy: an update for prescribers
Adv. Psychiatr. Treat.,
March 1, 2005;
11(2):
150 - 156.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Cowen
New drugs, old problems: REVISITING... PHARMACOLOGICAL MANAGEMENT OF TREATMENT-RESISTANT DEPRESSION
Adv. Psychiatr. Treat.,
January 1, 2005;
11(1):
19 - 27.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P Levack, J Graham, and J Kidd
Listen to the patient: quality of life of patients with recently diagnosed malignant cord compression in relation to their disability
Palliative Medicine,
October 1, 2004;
18(7):
594 - 601.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. R. Lingford-Hughes, S. Welch, and D. J. Nutt
Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology
J Psychopharmacol,
September 1, 2004;
18(3):
293 - 335.
[PDF]
|
|
|
|
|
|
|
J.-P. Lepine, V. Caillard, J.-C. Bisserbe, S. Troy, J.-M. Hotton, P. Boyer, and For the PREVERS Investigators
A Randomized, Placebo-Controlled Trial of Sertraline for Prophylactic Treatment of Highly Recurrent Major Depressive Disorder
Am J Psychiatry,
May 1, 2004;
161(5):
836 - 842.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. KENNEDY, R. ABBOTT, and E. S. PAYKEL
Longitudinal syndromal and sub-syndromal symptoms after severe depression: 10-year follow-up study
The British Journal of Psychiatry,
April 1, 2004;
184(4):
330 - 336.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Bailey
The Application of Good Clinical Practice to Challenge Tests
J Psychopharmacol,
March 1, 2004;
18(1):
16 - 16.
[PDF]
|
|
|
|
|
|
|
D. J. Nutt
Death and Dependence: Current Controversies over the Selective Serotonin Reuptake Inhibitors
J Psychopharmacol,
December 1, 2003;
17(4):
355 - 364.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Dwight-Johnson, I. T. Lagomasino, and G. M. Simpson
Psychopharmacology: Underuse of Evidence-Based Pharmacotherapies for Affective Disorders
Psychiatr Serv,
August 1, 2003;
54(8):
1076 - 1078.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Parker, I. M. Anderson, and P. Haddad
Clinical trials of antidepressant medications are producing meaningless results
The British Journal of Psychiatry,
August 1, 2003;
183(2):
102 - 104.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Keller
Past, Present, and Future Directions for Defining Optimal Treatment Outcome in Depression: Remission and Beyond
JAMA,
June 18, 2003;
289(23):
3152 - 3160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Nutt
British Association for Psychopharmacology Consensus on the Treatment of Bipolar Disorder
J Psychopharmacol,
June 1, 2003;
17(2):
147 - 147.
[PDF]
|
|
|
|
|
|
|
G. M. Goodwin
Evidence-Based Guidelines for Treating Bipolar Disorder: Recommendations from the British Association for Psychopharmacology
J Psychopharmacol,
June 1, 2003;
17(2):
149 - 173.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. Kirov and A. Korszun
The antidepressant debate should move on
The British Journal of Psychiatry,
June 1, 2003;
182(6):
551 - 551.
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. M. Anderson, P. M. Haddad, and J. Moncrieff
The antidepressant debate should move on * Author's reply
The British Journal of Psychiatry,
June 1, 2003;
182
(6):
551 - 552.
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. M. Anderson
Drug treatment of depression: reflections on the evidence
Adv. Psychiatr. Treat.,
January 1, 2003;
9(1):
11 - 20.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. A Furukawa, H. McGuire, and C. Barbui
Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review
BMJ,
November 2, 2002;
325(7371):
991 - 991.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. STIMPSON, N. AGRAWAL, and G. LEWIS
Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression: Systematic review
The British Journal of Psychiatry,
October 1, 2002;
181(4):
284 - 294.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Ferrier
Treatment-Resistant Mood Disorders
The British Journal of Psychiatry,
September 1, 2002;
181(3):
264 - 264.
[Full Text]
|
|
|
|
|
|
|
S. Marriott, C. Wright, and P. Lelliott
The clinical management of a patient with depressive disorder: a case vignette study to examine general practitioners' views
The Psychiatrist,
July 1, 2002;
26(7):
255 - 257.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. HICKS, S. V. ARGYROPOULOS, A. S. RICH, J. NASH, C. J. BELL, C. EDWARDS, D. J. NUTT, and S. J. WILSON
Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression
The British Journal of Psychiatry,
June 1, 2002;
180(6):
528 - 535.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. SMITH, C. DEMPSTER, J. GLANVILLE, N. FREEMANTLE, and I. ANDERSON
Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis
The British Journal of Psychiatry,
May 1, 2002;
180(5):
396 - 404.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. M. Anderson and J. G. Edwards
Guidelines for choice of selective serotonin reuptake inhibitor in depressive illness
Adv. Psychiatr. Treat.,
May 1, 2001;
7(3):
170 - 180.
[Full Text]
|
|
|
|
|
|
|
A. H. YOUNG
Recurrent unipolar depression requires prolonged treatment
The British Journal of Psychiatry,
April 1, 2001;
178(4):
294 - 295.
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. M Anderson
Meta-analytical studies on new antidepressants
Br. Med. Bull.,
March 1, 2001;
57(1):
161 - 178.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Peveler and T. Kendrick
Treatment delivery and guidelines in primary care: Depression and public health
Br. Med. Bull.,
March 1, 2001;
57(1):
193 - 206.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
